Pre-made Vobarilizumab biosimilar ( Bispecific Single Domains (VH-VH'), anti-IL6R;ALB therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-625
Anti-IL6R;ALB therapeutic antibody (Pre-made Vobarilizumab biosimilar,Bispecific Single Domains (VH-VH')) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Vobarilizumab (INN; development code ALX0061) is a humanized monoclonal antibody designed for the treatment of inflammatory autoimmune diseases.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-IL6R;ALB therapeutic antibody (Pre-made Vobarilizumab biosimilar,Bispecific Single Domains (VH-VH'))|
|Format||Bispecific Single Domains (VH-VH')|
|Highest_Clin_Trial (Jan '20)||Phase-II|
|100% SI Structure||None;None|
|99% SI Structure||None;None|
|95-98% SI Structure||None;None|
|Conditions Active||Rheumatoid arthritis;Systemic lupus erythematosus|
|Development Tech||Nanobody Technology|